AACR-NCI-EORTC Virtual International Conference On Molecular Targets and Cancer Therapeutics October 7 - October 10, 2021 Supporting Materials MDNA11 is a Long-Acting ‘Beta-Only’ IL-2 Agonist that Demonstrates a Safe and Durable Anti-tumor Immune Response 9.4 MB MDNA11 is a Long-Acting ‘Beta-Only’ IL-2 Agonist that Demonstrates a Safe and Durable Anti-tumor Immune Response 1.2 MB
MDNA11 is a Long-Acting ‘Beta-Only’ IL-2 Agonist that Demonstrates a Safe and Durable Anti-tumor Immune Response 9.4 MB
MDNA11 is a Long-Acting ‘Beta-Only’ IL-2 Agonist that Demonstrates a Safe and Durable Anti-tumor Immune Response 1.2 MB